202 related articles for article (PubMed ID: 25801936)
21. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds.
Al-Sanea MM; Ali Khan MS; Abdelazem AZ; Lee SH; Mok PL; Gamal M; Shaker ME; Afzal M; Youssif BGM; Omar NN
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385071
[TBL] [Abstract][Full Text] [Related]
23. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone.
Luo ZH; He SY; Chen BQ; Shi YP; Liu YM; Li CW; Wang QS
Chem Pharm Bull (Tokyo); 2012; 60(7):887-91. PubMed ID: 22790823
[TBL] [Abstract][Full Text] [Related]
26. Novel diarylamides and diarylureas with N-substitution dependent activity against medulloblastoma.
Lawson C; Ahmed Alta TB; Moschou G; Skamnaki V; Solovou TGA; Topham C; Hayes J; Snape TJ
Eur J Med Chem; 2021 Dec; 225():113751. PubMed ID: 34391032
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents.
Zhang C; Tan X; Feng J; Ding N; Li Y; Jin Z; Meng Q; Liu X; Hu C
Molecules; 2019 Jun; 24(11):. PubMed ID: 31167363
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH
Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.
Yao P; Zhai X; Liu D; Qi BH; Tan HL; Jin YC; Gong P
Arch Pharm (Weinheim); 2010 Jan; 343(1):17-23. PubMed ID: 19927308
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold.
Bao G; Du B; Ma Y; Zhao M; Gong P; Zhai X
Med Chem; 2016; 12(5):489-98. PubMed ID: 26740207
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.
Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML
Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
El-Gamal MI; Oh CH
Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.
Wang M; Xu S; Wu C; Liu X; Tao H; Huang Y; Liu Y; Zheng P; Zhu W
Bioorg Med Chem Lett; 2016 Nov; 26(22):5450-5454. PubMed ID: 27777009
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, activity and docking studies of phenylpyrimidine-carboxamide Sorafenib derivatives.
Wang W; Wu C; Wang J; Luo R; Wang C; Liu X; Li J; Zhu W; Zheng P
Bioorg Med Chem; 2016 Dec; 24(23):6166-6173. PubMed ID: 28340913
[TBL] [Abstract][Full Text] [Related]
38. [Synthesis and biological evaluation of sorafenib thiourea derivatives].
Yang Z; Fang Z; Wang ZX; Wei P
Yao Xue Xue Bao; 2011 Sep; 46(9):1093-7. PubMed ID: 22121780
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.
Lu C; Tang K; Li Y; Li P; Lin Z; Yin D; Chen X; Huang H
Eur J Med Chem; 2014 Apr; 77():351-60. PubMed ID: 24675135
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2.
Jung MH; El-Gamal MI; Abdel-Maksoud MS; Sim T; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2012 Jul; 22(13):4362-7. PubMed ID: 22647720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
